Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease

NCT00492531 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
74
Enrollment
NIH
Sponsor class

Stopped Subjects on drug were more likely to have severe pain crises requiring hospitalization.

Conditions

Interventions

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)